[PDF][PDF] Propelling Healthcare with Advanced Therapy Medicinal Products: A Policy

D Horgana, A Metspalub, MC Ouilladec… - 2020 - academia.edu
Recent advances in biomedicine are opening the door to new approaches, and treatment
and prevention are being transformed by novel medicines based on genetic engineering …

Propelling healthcare with advanced therapy medicinal products: a policy discussion

D Horgan, A Metspalu, MC Ouillade, D Athanasiou… - Biomedicine …, 2020 - karger.com
Recent advances in biomedicine are opening the door to new approaches, and treatment
and prevention are being transformed by novel medicines based on genetic engineering …

Challenges with advanced therapy medicinal products and how to meet them

Nature reviews Drug discovery, 2010 - nature.com
Advanced therapy medicinal products (ATMPs), which include gene therapy medicinal
products, somatic cell therapy medicinal products and tissue-engineered products, are at the …

[HTML][HTML] PNS106 Thinking Outside the Box: Sustainable Solutions to Drive Global Patient Access for Advanced Therapy Medicinal Products (ATMPs)

E Butler, J Whitehouse, A Satherley… - Value in …, 2020 - valueinhealthjournal.com
Objectives Successful adoption of Advanced Therapy Medicinal Products (ATMPs), with
potentially curative effects after one treatment cycle, can provide significant clinical and …

The underlying evidence for Advanced Therapy Medicinal Products

M Hoogendoorn - 2023 - studenttheses.uu.nl
Abstract Background: Advanced Therapy Medicinal Products (ATMPs) are novel medicines
that often offer new opportunities to treat conditions with a high unmet medical need. To …

(Committee for Advanced Therapies (CAT), CAT Scientific Secretariat), Challenges with advanced therapy medicinal products and how to meet them

CK Schneider, B Flamion, I Haunerova… - Nature Reviews. Drug …, 2010 - ikee.lib.auth.gr
Advanced therapy medicinal products (ATMPs), which include gene therapy medicinal
products, somatic cell therapy medicinal products and tissue-engineered products, are at the …

Payer and implementation challenges with advanced therapy medicinal products (ATMPs)

J Spoors, A Miners, J Cairns, D Palnoch… - BioDrugs, 2021 - Springer
Advanced therapy medicinal products (ATMPs) are a dynamic and current topic for
healthcare systems, with new products progressing to market at an increasing rate. ATMPs …

Advanced therapies push regulatory boundaries: Novel therapeutic approaches require more regulatory flexibility and transparency

P Hunter - EMBO reports, 2017 - embopress.org
The regulation of new medical applica-tions has always been lagging behind the science
that enabled these therapies in the first place, but emerging therapeutic approaches are …

[HTML][HTML] An update on clinical and economic evidence requirements for advanced-therapy medicinal products in Europe

E Anastasaki, A Walker, S Bradshaw - Value in Health, 2014 - valueinhealthjournal.com
Objectives Advanced-therapy medicinal products (ATMPs), such as gene therapy, cell
therapy and tissue engineering are a new class of medicines in the EU. ATMPs offer …

Development of advanced therapy medicinal products: a case for early scientific advice

M Brunner, B Jilma - Clinical Pharmacology: Current Topics and Case …, 2016 - Springer
Advanced therapy medicinal products (ATMPs)–gene therapy medicinal products, somatic
cell therapy medicinal products and tissue-engineered products–are currently the most …